PDX INSIGHTS
PIONEERING CANCER RESEARCH
Model Details

Patient Information for Model: TCCC-EWS82

Model Contact
Model: TCCC-EWS82
Model Contact: Nino Rainusso
Institution: TCH Sarcoma PDX Program
Email: ncrainuss@texaschildrens.org

Patient Information
Clinical Timeline


Clinical Information at Collection
Clinical Biomarkers/Mutations
Pathology Information at Collection

Model Information for Model: TCCC-EWS82

Model Details - Initial Implantation of Patient Tissue
Mutations (Cancer Gene Census List)
Mutation data is currently not available.

CNV
There are no omics data for this model.


Histology Information for Model: TCCC-EWS82
There are no histology images for this model.













Metastasis Information for Model: TCCC-EWS82
 
Patient
PDX
Bone
Lung

Patient Treatment Information for Model: TCCC-EWS82

Event IdTreatmentTreatment SettingAge at StartAge at EndDurationClinical ResponseReason Stopped
10Vicristine, Doxorubicin, Cyclophosphamide/Ifosfamide, EtoposideNeoadjuvant14.9115.25124 daysPartial responseLocal control with raditon therapy
20Vicristine, Doxorubicin, Cyclophosphamide/Ifosfamide, EtoposideAdjuvant15.2515.4158 daysLost of follow-up (transfer care to other institution)













Please wait...